RxDoctor Payments Data
★ My doctorsLook up a doctor →

Shaneeka Hamlett

Family · San Antonio, TXNPI 1891278511

Payments from drug & device makers

$12,551in general payments, 2019–2025

Across 568 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$1K
  • Astellas Pharma US Inc$569
  • Merck$478
  • Amgen$469
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$11,94295%
  • Education$6095%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)52$1,080
Novartis57$1,059
AstraZeneca(2 entities)40$1,042
Astellas Pharma US Inc17$569
Merck22$478
Amgen22$469
Gilead(2 entities)17$452
Bristol Myers Squibb20$393
Sobi, Inc10$366
Incyte Corporation19$364
Sanofi16$352
Genentech USA, Inc.14$341
Bayer13$324
Eisai Inc.18$310
Takeda Pharmaceuticals U.S.A., Inc.13$305
Karyopharm Therapeutics Inc.14$282
Regeneron Healthcare Solutions, Inc.9$269
Pharmaessentia USA Corporation6$265
Daiichi Sankyo Inc.13$252
E.r. Squibb & Sons, L.L.C.7$247
Ipsen Biopharmaceuticals, Inc14$246
AbbVie11$230
GSK11$229
Lilly USA, LLC9$197
Organon15$177
Jazz Pharmaceuticals Inc.7$143
Exelixis Inc.3$130
Pfizer7$122
Tersera Therapeutics LLC4$103
ADC Therapeutics America, Inc.5$99
Kyowa Kirin, Inc.5$97
Rigel Pharmaceuticals, Inc.5$91
Morphosys, US Inc.4$90
Seagen Inc.5$87
Servier Pharmaceuticals LLC5$86
Taiho Oncology, Inc.4$78
Octapharma USA, Inc.4$73
Array Biopharma Inc3$71
AVEO Pharmaceuticals, Inc.3$70
Adaptive Biotechnologies Corporation3$60
Pharmacosmos Therapeutics Inc.2$59
EMD Serono, Inc.3$58
Sumitomo Pharma America, Inc.2$54
Deciphera Pharmaceuticals Inc.2$53
Legend Biotech USA Inc.2$46
Pharmacyclics LLC, An Abbvie Company3$46
Amneal Pharmaceuticals LLC2$45
Genmab U.S., Inc.2$44
Sanofi-aventis U.S. LLC1$42
Agios Pharmaceuticals, Inc.2$41
Puma Biotechnology, Inc.2$37
Blueprint Medicines Corporation2$36
Dova Pharmaceuticals2$36
Shield Therapeutics Inc2$34
Fennec Pharmaceuticals, Inc.2$29
Azurity Pharmaceuticals, Inc.1$22
Tempus AI, Inc1$22
Tolmar, Inc.1$19
Boehringer Ingelheim1$19
Dendreon Pharmaceuticals LLC1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,551 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Medicare billing

Part B allowed, 2024
$4,829
Medicare patients
28
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →